About Utopic Tech
Utopic Tech is a company based in Pune (India) founded in 2019 by Mehul Baldwa. Utopic Tech has raised $39.94 thousand across 2 funding rounds from investors including Pfizer, Startups at Venture Center and Social Alpha. Utopic Tech offers products and services including Creasens. Utopic Tech operates in a competitive market with competitors including MediBeacon, Physidia, FAST BioMedical, Accunea and Prantae Solutions, among others.
- Headquarter Pune, India
- Founders Mehul Baldwa
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Utopic Tech Private Limited
- Date of Incorporation 14 Oct, 2019
- Jurisdiction Indore, Madhya Pradesh, India
-
Annual Revenue
$12.99 K (USD)0as on Mar 31, 2022
-
Net Profit
-$10.8 K (USD)0as on Mar 31, 2022
-
EBITDA
-$22.9 K (USD)0as on Mar 31, 2022
-
Total Equity Funding
$39.94 K (USD)
in 2 rounds
-
Latest Funding Round
$29.62 K (USD), Grant
Nov 11, 2024
-
Investors
Pfizer
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Utopic Tech
Utopic Tech offers a comprehensive portfolio of products and services, including Creasens.
Measures creatinine from finger prick for quick kidney diagnosis.
Funding Insights of Utopic Tech
Utopic Tech has successfully raised a total of $39.94K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $29.62 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Utopic Tech
Utopic Tech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Pfizer, Startups at Venture Center and Social Alpha.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sustainable startups are supported via innovation curation and venture funding.
|
Locked | Locked | Locked | |
|
Startup incubator focused on science business
|
Locked | Locked | Locked | |
|
Pharmaceutical products for treating multiple diseases are provided.
|
Locked | Locked | Locked |
Investor details for Utopic Tech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Utopic Tech
Investment portfolio details for Utopic Tech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Utopic Tech
Detailed financials for Utopic Tech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Utopic Tech Comparisons
Peer comparison for Utopic Tech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Utopic Tech
Utopic Tech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediBeacon, Physidia, FAST BioMedical, Accunea and Prantae Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive optical monitoring of kidney function is developed.
|
|
| Locked | Locked | Locked |
Manufacturer of a hemodialysis monitoring device
|
|
| Locked | Locked | Locked |
Develops fluorescent in-vivo markers for measuring plasma volume and mGFR.
|
|
| Locked | Locked | Locked |
Monitoring devices for kidney function are developed by Accunea.
|
|
| Locked | Locked | Locked |
Medical imaging and devices for pregnancy monitoring are developed.
|
Detailed competitors of Utopic Tech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Utopic Tech
Complete news archive for Utopic Tech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Utopic Tech
Utopic Tech was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Utopic Tech is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Mehul Baldwa is the current CEO of Utopic Tech. They have also founded this company.
Utopic Tech is a funded company, having raised a total of $39.94K across 2 funding rounds to date.
Annual revenue of Utopic Tech is $12.99K as on Mar 31, 2022.
Utopic Tech was founded in 2019 in Pune, India, and operates in the medical devices sector. Focus is placed on kidney-related health solutions, with the primary product Creasens enabling creatinine measurement from finger-prick samples in under a minute. Development and management of diagnostic tools for renal conditions are prioritized, supporting clinical applications in healthcare settings across the region.
Utopic Tech's top competitors include MediBeacon, Physidia and Prantae Solutions.
Utopic Tech offers Creasens.
Utopic Tech has 3 investors. Key investors include Pfizer, Startups at Venture Center, and Social Alpha.
The valuation of Utopic Tech is $345.57K as of Oct 2021.